Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about ALDH2: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
No summary available yet. View on Wiki →
| Gene Symbol | ALDH2 |
| Full Name | Aldehyde Dehydrogenase 2 |
| Aliases | ALDH-E2 |
| Chromosome | 12q24.12 |
| Protein Type | Enzyme |
| Function | Mitochondrial aldehyde detoxification enzyme |
| Subcellular Localization | the mitochondrial matrix. Each subunit contains: |
| Molecular Weight | 56.4 kDa |
| Amino Acids | 517 |
| Pathways | Ethanol metabolism, Oxidative stress response |
| UniProt ID | P05091 |
| Ensembl ID | ENSG00000111275 |
| GeneCards | ALDH2 |
| Human Protein Atlas | ALDH2 |
| 4-HNE | Substrate |
| Associated Diseases | Als, Atherosclerosis, Cardiovascular, Coronary Artery Disease, Infection, Inflammation |
| Interactions | FASN, SREBF1, MDH2, TNF, IL6, IL1B |
| KG Connections | 112 knowledge graph edges |
| Databases | GeneCardsNCBI GeneHPASTRING |
Knowledge base pages for this entity
graph TD
ALDH2["ALDH2"] -->|"associated"| Inflammation["Inflammation"]
style Inflammation fill:#1a2a3a,stroke:#ef5350,stroke-width:1px,color:#e0e0e0
ALDH2["ALDH2"] -->|"regulates"| mitochondrial_integrity["mitochondrial integrity"]
style mitochondrial_integrity fill:#1a2a3a,stroke:#ffd54f,stroke-width:1px,color:#e0e0e0
ALDH2["ALDH2"] -->|"therapeutic target"| Ischemia["Ischemia"]
style Ischemia fill:#1a2a3a,stroke:#ef5350,stroke-width:1px,color:#e0e0e0
ALDH2["ALDH2"] -->|"therapeutic target"| Ms["Ms"]
style Ms fill:#1a2a3a,stroke:#ef5350,stroke-width:1px,color:#e0e0e0
ALDH2["ALDH2"] -->|"therapeutic target"| Tumor["Tumor"]
style Tumor fill:#1a2a3a,stroke:#ef5350,stroke-width:1px,color:#e0e0e0
ALDH2["ALDH2"] -->|"therapeutic target"| Parkinson["Parkinson"]
style Parkinson fill:#1a2a3a,stroke:#ef5350,stroke-width:1px,color:#e0e0e0
ALDH2["ALDH2"] -->|"therapeutic target"| Alzheimer["Alzheimer"]
style Alzheimer fill:#1a2a3a,stroke:#ef5350,stroke-width:1px,color:#e0e0e0
FERROPTOSIS["FERROPTOSIS"] -->|"activates"| ALDH2["ALDH2"]
style FERROPTOSIS fill:#1a2a3a,stroke:#ce93d8,stroke-width:1px,color:#e0e0e0
GPX4["GPX4"] -->|"therapeutic target"| ALDH2["ALDH2"]
style GPX4 fill:#1a2a3a,stroke:#ce93d8,stroke-width:1px,color:#e0e0e0
OTUD5["OTUD5"] -->|"therapeutic target"| ALDH2["ALDH2"]
style OTUD5 fill:#1a2a3a,stroke:#ce93d8,stroke-width:1px,color:#e0e0e0
PARKINSON_S_DISEASE["PARKINSON'S DISEASE"] -->|"therapeutic target"| ALDH2["ALDH2"]
style PARKINSON_S_DISEASE fill:#1a2a3a,stroke:#ce93d8,stroke-width:1px,color:#e0e0e0
MTOR["MTOR"] -->|"associated"| ALDH2["ALDH2"]
style MTOR fill:#1a2a3a,stroke:#ce93d8,stroke-width:1px,color:#e0e0e0
style ALDH2 fill:#4a1a6b,stroke:#4fc3f7,stroke-width:2px,color:#e0e0e0,font-weight:bold| Target | Relation | Type | Str |
|---|---|---|---|
| Inflammation | associated_with | disease | 0.75 |
| mitochondrial integrity | regulates | process | 0.70 |
| Ischemia | therapeutic_target | disease | 0.65 |
| Ms | therapeutic_target | disease | 0.65 |
| Tumor | therapeutic_target | disease | 0.65 |
| Parkinson | therapeutic_target | disease | 0.65 |
| Alzheimer | therapeutic_target | disease | 0.65 |
| Als | therapeutic_target | disease | 0.65 |
| Als | expressed_in | disease | 0.65 |
| Ms | expressed_in | disease | 0.65 |
| Cancer | expressed_in | disease | 0.65 |
| Carcinoma | expressed_in | disease | 0.65 |
| Sepsis | therapeutic_target | disease | 0.65 |
| Atherosclerosis | therapeutic_target | disease | 0.65 |
| Coronary Artery Disease | associated_with | disease | 0.65 |
| Stroke | associated_with | disease | 0.65 |
| Als | associated_with | disease | 0.65 |
| Infection | associated_with | disease | 0.65 |
| Ischemia | inhibits | disease | 0.65 |
| Als | regulates | disease | 0.65 |
| Stroke | inhibits | disease | 0.65 |
| Atherosclerosis | associated_with | disease | 0.65 |
| Cardiovascular | associated_with | disease | 0.65 |
| RANK | expressed_in | gene | 0.60 |
| HMGCR | therapeutic_target | gene | 0.60 |
| FASN | activates | gene | 0.60 |
| SREBF1 | activates | gene | 0.60 |
| AKT | therapeutic_target | gene | 0.60 |
| APOE | associated_with | gene | 0.60 |
| MDH2 | interacts_with | gene | 0.60 |
| TNF | activates | gene | 0.60 |
| MTOR | associated_with | gene | 0.60 |
| TARDBP | regulates | gene | 0.60 |
| LGALS1 | regulates | gene | 0.60 |
| FASN | regulates | gene | 0.60 |
| CDK1 | regulates | gene | 0.60 |
| CTSB | regulates | gene | 0.60 |
| CTSD | regulates | gene | 0.60 |
| IL6 | activates | gene | 0.60 |
| PPARG | associated_with | gene | 0.60 |
| AKT | associated_with | gene | 0.60 |
| CGAS | associated_with | gene | 0.60 |
| IL1B | activates | gene | 0.60 |
| PPARA | activates | gene | 0.60 |
| Ferroptosis | activates | pathway | 0.60 |
| Mapk | associated_with | pathway | 0.60 |
| Mtor | associated_with | pathway | 0.60 |
| Mitophagy | activates | pathway | 0.60 |
| Glycolysis | activates | pathway | 0.60 |
| Oxidative Stress | therapeutic_target | pathway | 0.60 |
| Source | Relation | Type | Str |
|---|---|---|---|
| GPX4 | therapeutic_target | gene | 0.60 |
| OTUD5 | therapeutic_target | gene | 0.60 |
| MTOR | associated_with | gene | 0.60 |
| IGF2R | associated_with | gene | 0.60 |
| CAV1 | associated_with | gene | 0.60 |
| COMT | associated_with | gene | 0.60 |
| HSP90AA1 | associated_with | gene | 0.60 |
| HSPA1A | associated_with | gene | 0.60 |
| SOD2 | expressed_in | gene | 0.60 |
| SIRT3 | activates | gene | 0.60 |
| TNF | activates | gene | 0.60 |
| IL1B | activates | gene | 0.60 |
| PPARA | activates | gene | 0.60 |
| PI3K | therapeutic_target | gene | 0.60 |
| IL6 | activates | gene | 0.60 |
| PPARG | therapeutic_target | gene | 0.60 |
| MMP12 | associated_with | gene | 0.60 |
| HDAC9 | associated_with | gene | 0.60 |
| FASN | activates | gene | 0.60 |
| HMGCR | therapeutic_target | gene | 0.60 |
| SREBF1 | activates | gene | 0.60 |
| AKT | therapeutic_target | gene | 0.60 |
| HMGCR | associated_with | gene | 0.60 |
| PI3K | associated_with | gene | 0.60 |
| USP14 | associated_with | gene | 0.60 |
| FERROPTOSIS | activates | gene | 0.60 |
| PARKINSON'S DISEASE | therapeutic_target | gene | 0.60 |
| NEURODEGENERATIVE DISEASES | associated_with | gene | 0.60 |
| ALZHEIMER'S DISEASE | therapeutic_target | gene | 0.60 |
| INFLAMMATION | associated_with | gene | 0.60 |
| MITOPHAGY | activates | gene | 0.60 |
| MITOCHONDRIAL DYSFUNCTION | activates | gene | 0.60 |
| ROS | therapeutic_target | gene | 0.60 |
| OXIDATIVE STRESS | therapeutic_target | gene | 0.60 |
| PERICYTE | associated_with | gene | 0.60 |
| AND | activates | gene | 0.60 |
| MAPK | therapeutic_target | gene | 0.60 |
| AND | associated_with | gene | 0.60 |
| PARKINSON | therapeutic_target | gene | 0.60 |
| MAPK | associated_with | gene | 0.60 |
| GENES | associated_with | gene | 0.60 |
| ALZHEIMER | therapeutic_target | gene | 0.60 |
| STROKE | inhibits | gene | 0.60 |
| LDHA | regulates | gene | 0.60 |
| ACACA | activates | gene | 0.60 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| No targeting hypotheses | |||
Scientific analyses that reference this entity
No analyses mention this entity
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||